HomeSHPH • NASDAQ
Shuttle Pharmaceuticals Holdings Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.95M | 113.11% |
Net income | -3.05M | -76.37% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.95M | -113.33% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.51M | 7.75% |
Total assets | 5.31M | 11.70% |
Total liabilities | 2.02M | 1.63% |
Total equity | 3.29M | — |
Shares outstanding | 10.98M | — |
Price to book | 0.36 | — |
Return on assets | -188.78% | — |
Return on capital | -235.27% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -3.05M | -76.37% |
Cash from operations | -2.53M | -103.94% |
Cash from investing | — | — |
Cash from financing | 5.12M | 12,898.47% |
Net change in cash | 2.59M | 320.11% |
Free cash flow | -1.16M | -90.19% |
Previous close
$0.18
Day range
$0.18 - $0.18
Year range
$0.16 - $4.30
Market cap
1.98M USD
Avg Volume
8.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2012
Headquarters
Website
Employees
9